Journal Article DKFZ-2025-03045

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary disease.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Springer Nature [London]

Scientific reports 15(1), 44418 () [10.1038/s41598-025-32565-y]
 GO

Abstract: Cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are muco-obstructive lung diseases. Knowledge of molecular processes has much improved therapeutic options in CF, whereas much less is known for COPD, a disease affecting an increasing number of patients. Here, we report a multilayer workflow integrating microbiome, inflammation and proteome profiling with clinical data to identify disease specific characteristics in sputum. Our proof-of-concept study shows that CF sputum is dominated by Pseudomonas and Staphylococcus, exhibits heightened neutrophilic inflammation, and a severe protease-antiprotease imbalance. In contrast, COPD displays heterogeneous microbiome composition, eosinophilic inflammation, and altered extracellular matrix remodeling. Proteome-based cellular deconvolution identifies disease-specific immune cell signatures, underscoring the complexity, especially in COPD. Multi-omics factor analysis suggests that matrisome and nucleotide metabolism changes may act as disease discriminators, though future confirmation in larger cohorts is needed. These findings highlight the potential of our integrated approach to uncover sputum biomarkers as tools for patient stratification and personalized therapeutic strategies in CF and COPD.

Keyword(s): Cystic Fibrosis: metabolism (MeSH) ; Cystic Fibrosis: microbiology (MeSH) ; Humans (MeSH) ; Pulmonary Disease, Chronic Obstructive: metabolism (MeSH) ; Pulmonary Disease, Chronic Obstructive: microbiology (MeSH) ; Sputum: microbiology (MeSH) ; Sputum: metabolism (MeSH) ; Biomarkers: metabolism (MeSH) ; Biomarkers: analysis (MeSH) ; Female (MeSH) ; Male (MeSH) ; Microbiota (MeSH) ; Proteome (MeSH) ; Proteomics: methods (MeSH) ; Adult (MeSH) ; Biomarkers ; COPD ; Cystic fibrosis ; Microbiome ; Multi-omics ; Proteomics ; Biomarkers ; Proteome

Classification:

Note: #EA:B200#LA:B200#

Contributing Institute(s):
  1. B200 Systembiologie der Signaltransduktion (B200)
  2. Proteomics (W120)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2025
Database coverage:
Medline ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2025-12-30, last modified 2025-12-31


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)